Yves Saint Laurent All Hours Foundation Broad Spectrum Spf 20 Sunscreen Luminous Matte Foundation Lotion
NDC Package 51150-712-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Yves Saint Laurent All Hours Foundation Broad Spectrum Spf 20 Sunscreen Luminous Matte Foundation (octinoxate and titanium dioxide) lotions is for sunscreen use:shake well before useapply liberally 15 minutes before sun exposurereapply at least every 2 hoursuse a water resistant sunscreen if swimming or sweatingSun Protection Measures. This formulation utilizes a lotion delivery system. Marketed by Sicos Et Cie, this product is identified by NDC 51150-712 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
51150-712-01
Package Description
1 BOTTLE in 1 CARTON / 25 mL in 1 BOTTLE
Product Code
51150-712
11-Digit Billing Format
51150071201

Clinical Specifications

Proprietary Name
Yves Saint Laurent All Hours Foundation Broad Spectrum Spf 20 Sunscreen Luminous Matte Foundation
Non-Proprietary Name
Octinoxate And Titanium Dioxide
Substance Name
Octinoxate; Titanium Dioxide
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
For sunscreen use:shake well before useapply liberally 15 minutes before sun exposurereapply at least every 2 hoursuse a water resistant sunscreen if swimming or sweatingSun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:                limit time in the sun, especially from 10 a.m. - 2 p.m.                wear long-sleeved shirts, pants, hats and sunglasseschildren under 6 months of age: Ask a doctor

Regulatory & Marketing

Labeler Name
Sicos Et Cie
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-25-2022
End Marketing Date
06-28-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (51150-712). Click a package code to view its specific billing and regulatory data.

51150-712-02
4.2 mL in 1 PACKAGE
51150-712-03
1 mL in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51150-712-01 identifies a specific commercial package of 1 bottle in 1 carton / 25 ml in 1 bottle of Yves Saint Laurent All Hours Foundation Broad Spectrum Spf 20 Sunscreen Luminous Matte Foundation, a human over the counter drug labeled by Sicos Et Cie. This lotion is formulated for topical use and contains octinoxate; titanium dioxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sicos Et Cie on July 25, 2022.

How is this Sicos Et Cie product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51150071201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51150-712-01
11-Digit CMS (5-4-2)
51150-0712-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.